From sick care to healthspan: educating the longevity physician for health maintenance and health promotion Authors: Dominik Thor, David Barzilai, Yu-Xuan Lyu, Luiza Spiru Published: 2025 ABSTRACT AbstractThis paper focuses specifically on the education and upskilling of medical doctors, proposing how longevity-related competencies can be incorporated first through continuing medical education (CME) pathways and, eventually, into formal medical curricula. As longevity medicine evolves from research into clinical practice, education has emerged as its defining challenge. While the science of ageing advances rapidly, most physicians remain unprepared to translate biological, technological, and preventive insights into responsible medical care. Emerging foundational fields such as biogerontology, which investigates the biological mechanisms of ageing across organisms, and its clinically oriented derivative geroscience, have created new expectations for translational capacity in healthcare. This paper extends previous conceptual work by outlining potential educational domains, proposing a structured education, and outlining a pedagogical and accreditation model for incorporating longevity-related competencies into medical training pathways. The framework integrates geroscience, digital diagnostics, and healthspan-oriented care within established medical education and quality assurance standards. By exploring potential pathways from postgraduate to continuing education, longevity medicine may contribute to more coherent and evidence-aligned practice. Education may represent one enabling factor in efforts to shift, where feasible, from predominantly reactive care toward more proactive approaches to health maintenance.Keywords: Longevity medicine, Medical education, Geroscience, Healthspan Introduction The scientific and clinical study of ageing has progressed through several definitional stages, each expanding the scope of inquiry. Gerontology initially provided a multidisciplinary framework for understanding ageing across biological, psychological, and social domains, followed by geriatrics, which formalised the clinical care of older adults as a medical specialty. With advances in molecular biology, biogerontology emerged as a discipline focused on uncovering the cellular and molecular mechanisms of ageing across species (Rattan 2024). Only later did geroscience develop as a translational extension of biogerontology, emphasizing how ageing biology contributes to disease vulnerability and how these pathways might be clinically targeted to improve human healthspan (Kennedy et al. 2014). Acknowledging this historical trajectory may provide useful context for considering the development of longevity medicine, as it highlights the scientific foundations upon which newer translational concepts are built. Longevity medicine is increasingly discussed as an advanced, personalised form of preventive medicine that integrates mechanistic insights from biogerontology and geroscience with modern diagnostic and data-driven technologies to extend healthspan. Rooted in the use of deep biomarkers of ageing, digital phenotyping, and artificial intelligence–supported risk assessment, longevity medicine seeks to move beyond the management of age-related disease toward earlier detection, personalised prevention, and targeted modulation of ageing biology. In contrast to geriatrics, which focuses on multimorbidity and functional decline in later life, longevity medicine applies ageing-science principles across the adult lifespan to preserve physiological resilience and reduce the burden of unhealthy ageing. As such, it may serve as a translational bridge between basic ageing research and new models of proactive, precision-oriented clinical care. It is important to clarify that the proposed competencies are not intended to replace or duplicate the established gatekeeper function of general practitioners within European health systems. In most EU countries, GPs already coordinate access to diagnostics, specialist referrals, and hospital-based investigations. The intention of this framework is therefore not to introduce a new clinical role, but to describe how geroscience-related competencies could be integrated into existing professional pathways. Longevity medicine, as outlined here, is conceptualised as an upskilling domain situated within current referral and governance structures, enabling physicians to incorporate mechanistic ageing science, biological-age biomarkers, and long-horizon risk assessment into routine preventive care without altering established system architecture. Longevity medicine is further not intended as a rebranding of geriatrics but may be viewed as a complementary upstream discipline. Whereas geriatrics manages multimorbidity, functional decline, and complex care needs typically arising after age 70, longevity medicine applies geroscience principles from early midlife onward, focusing on biological-age diagnostics, early detection of risk trajectories, and personalised prevention decades before frailty emerges. Table 1 outlines areas of overlap and areas unique to each discipline, suggesting that the two disciplines may be synergistic rather than competing. Table 1Comparison between geriatrics and longevity medicineGeriatricsLongevity medicinePrimary patient populationAdults ≥ 70 years; individuals with frailty, multimorbidity, cognitive impairmentAdults across the lifespan, with emphasis on midlife and preclinical risk trajectoriesClinical focusFunctional preservation, multimorbidity management, care coordination, polypharmacy optimisationEarly risk detection, prevention of age-related decline, optimisation of physiological resilienceDiagnostic orientationClinical assessment, functional measures (ADLs/IADLs), geriatric syndromes, cognitive evaluationBiological age estimation, multi-domain biomarkers, digital phenotyping, geroscience-informed risk stratificationIntervention frameworkSymptom management, reduction of treatment burden, fall prevention, support for independence, caregiver supportBehavioural and lifestyle optimisation, metabolic and cardiometabolic risk reduction, targeted geroprotective therapies (where evidence-based)Time horizonShort- to medium-term care focusing on quality of life and safetyLong-term prevention spanning decades before the onset of frailty or multimorbidityCore competency setComprehensive geriatric assessment, multimorbidity management, deprescribing, interprofessional careBiomarker interpretation, geroscience translation, personalised prevention planning, integration of digital and AI-supported diagnosticsPatient goals and preferencesAutonomy, comfort, reduction of care complexity, social support, caregiver coordinationMaintaining resilience, delaying functional decline, extending healthspan, long-term behavioural changeHealth system positioningEstablished medical specialty with defined regulatory frameworksCross-specialty competency domain; emerging consultative role integrated into existing disciplinesRelationship between fieldsDownstream management of ageing-related declineUpstream prevention and risk modulation; complements geriatrics by acting earlier in the ageing trajectory Comparison between geriatrics and longevity medicine The comparison table above is not intended to suggest the creation of a parallel specialty or a standalone clinical category positioned alongside geriatrics. Rather, it serves to conceptually differentiate upstream, geroscience-informed prevention from downstream management of multimorbidity in older adults. The delineation highlights differing orientations rather than distinct professions. In practice, the competencies associated with longevity medicine are expected to be adopted by existing clinicians—most commonly GPs, internists, endocrinologists, or preventive medicine specialists—depending on local system structures. Despite growing public and professional interest, longevity medicine remains conceptually diffuse and operationally inconsistent. Physicians today face a growing body of geroscience insights, yet few have the training to translate them responsibly into practice. The result may contribute to a perceived gap between measurable biomarkers and clinically actionable guidance. Developing longevity-related competencies among clinicians may be an important step in supporting responsible translation of longevity science. Existing programmes such as the MSc Health, Ageing and Society at Leiden University illustrate meaningful progress in multidisciplinary ageing education. However, these initiatives are not designed as clinical upskilling pathways for licensed physicians and therefore do not replace the need for structured longevity medicine training of the type discussed in this article. Prior authors have already highlighted the need to translate advances in longevity science into clinical practice and to implement structured longevity education for health-care providers (Bischof et al. 2021), but did not propose concrete frameworks or curricular guidelines, leaving the practical implementation of longevity training for physicians largely undefined. In Bridging Expectations and Science (Yu et al. 2025), it was argued that longevity medicine must evolve beyond enthusiasm and expectation to align with measurable scientific progress. Since that publication, one challenge has become increasingly apparent: while research in ageing biology has accelerated, the clinical capacity to interpret and apply this knowledge has not kept pace. Recent work has broadened the discussion by emphasizing that education in healthy longevity is not merely a professional competency but a structural prerequisite for transitioning from disease-centered care to a healthspan-oriented healthcare model. Meij and colleagues argue that healthy longevity medicine reshapes the relationship between citizens and healthcare systems, requiring widespread health literacy, shared knowledge ownership, and new pedagogical roles for physicians. Their framework highlights that the shift toward precision geromedicine demands educational reform at both societal and professional levels, reinforcing the need for harmonised curricula and competency development across disciplines (Meij et al. 2025). Building on Bridging Expectations and Science (Yu et al. 2025), this paper moves from conceptual alignment to educational implementation. It argues that without structured physician training, geroscience will remain largely confined to research, with limited clinical translation. By proposing a concrete educational model, this work seeks to define the competencies, learning pathways, and institutional frameworks that could support the development of longevity-related practice within existing medical structures. The following sections outline the rationale, core curricular domains, pedagogical structure, and accreditation framework necessary to operationalize this vision. Given its translational nature, longevity medicine sits at the intersection of biogerontology, preventive medicine, and clinical practice. The pedagogical challenges described in this manuscript are directly related to enabling the clinical application of ageing-biology discoveries—a central concern for the biogerontology community. Furthermore, longevity medicine does not replace established domains such as Social & Preventive Medicine but builds upon them by integrating molecular ageing science, digital diagnostics, and personalised prevention into their existing frameworks. This article therefore aims to complement, rather than replace, current medical education structures by proposing how traditional preventive disciplines can be expanded to incorporate advancements in ageing biology. To avoid creating parallel infrastructures, longevity medicine is conceptualised as a cross-cutting competency integrated into primary care in gatekeeper systems, and as a consultative subspecialty role in specialist-led systems, similar to endocrinology for metabolic risk. This positioning ensures compatibility with current referral structures and reimbursement pathways. Given that longevity medicine depends on clinically regulated diagnostics and interventions, the training frameworks proposed in this manuscript are directed exclusively toward physicians and do not extend to allied health or wellness practitioners. At the same time, the holistic and multidisciplinary nature of longevity science suggests that complementary training pathways for nurses, pharmacists, and other licensed healthcare professionals should be considered to support coordinated care, optimise patient outcomes, and uphold quality standards. The rationale for structured training Traditional medical education remains oriented toward acute care and disease management. Preventive and systems-level approaches, central to longevity practice, are rarely emphasized. The shift from sick care toward greater emphasis on health maintenance may benefit from extending existing professional competency profiles and supporting the role of longevity physicians as clinicians who understand the hallmarks of aging (López-Otín et al. 2023), interpret biological age biomarkers, integrate lifestyle and pharmacological interventions, and recognize the ethical and regulatory boundaries of novel therapies. Comparable, though not identical, developments occurred, with fields such as endocrinology, cardiometabolic medicine, and genomic medicine—each requiring new training structures before gaining clinical legitimacy. Without structured training, longevity-related practices may be vulnerable to some of the challenges observed in early wellness markets, such as heterogeneity and uneven evidence quality. Establishing accredited education may help practitioners discern evidence-based interventions from speculative or commercially driven claims, reinforcing public trust and professional integrity. Without structured education, longevity medicine risks fragmentation and premature application of unvalidated interventions. Postgraduate and CME-based programs can provide the scaffolding for scientific rigor, standardization, and public trust, and may support the development of longevity-related practice within responsible boundaries. To establish continuity between conventional preventive geriatrics and emerging longevity medicine, the proposed framework emphasizes integration rather than replacement. The competencies outlined build upon geriatric principles—functional assessment, multimorbidity management, and patient-centered prevention—while extending them through geroscience and biological-age diagnostics. This approach may help bridge the care of older adults with earlier preventive strategies across the adult lifespan, aligning longevity medicine with recognized public-health and geriatric models of prevention. It therefore situates longevity education within the established continuum of medical education rather than as a separate or competing paradigm. The added value of this framework lies not in redefining the gatekeeper function—already well established in European healthcare systems—but in addressing a gap in formal physician training related to ageing biology, biomarker interpretation, digital phenotyping, and long-term risk stratification. These domains are not currently included in standard medical curricula or in typical GP or specialist training pathways. By outlining harmonised competencies, governance principles, and educational pathways, the proposed framework supports clinicians in responsibly integrating emerging geroscience insights into practice, thereby improving clinical consistency and reducing reliance on commercially driven or unregulated approaches. Core domains of longevity medicine education A coherent educational framework for longevity physicians should integrate the following domains: Foundations of Biogerontology and Geroscience—Foundational scientific training should begin with biogerontology, which provides the mechanistic understanding of ageing biology, and then extend into geroscience, which applies these mechanisms to human ageing, disease vulnerability, and intervention development. This includes molecular mechanisms of ageing, hallmarks of ageing, genetics and epigenetics, and biomarker interpretation. Foundations of Biogerontology and Geroscience—Foundational scientific training should begin with biogerontology, which provides the mechanistic understanding of ageing biology, and then extend into geroscience, which applies these mechanisms to human ageing, disease vulnerability, and intervention development. This includes molecular mechanisms of ageing, hallmarks of ageing, genetics and epigenetics, and biomarker interpretation. Diagnostics and Technology—Biological age testing, multi-omics, digital biomarkers, wearable data integration, and AI-assisted decision support. Diagnostics and Technology—Biological age testing, multi-omics, digital biomarkers, wearable data integration, and AI-assisted decision support. Preventive and Clinical Longevity Practice—Risk assessment, early detection, multimodal interventions (nutrition, exercise, sleep, stress management), and evidence-based use of geroprotectors. Preventive and Clinical Longevity Practice—Risk assessment, early detection, multimodal interventions (nutrition, exercise, sleep, stress management), and evidence-based use of geroprotectors. Translational and Regulatory Science—Clinical trial design, endpoints for healthspan studies, regulatory frameworks (FDA, EMA, Swissmedic), and ethical and regulatory compliance in clinical research and innovation. Translational and Regulatory Science—Clinical trial design, endpoints for healthspan studies, regulatory frameworks (FDA, EMA, Swissmedic), and ethical and regulatory compliance in clinical research and innovation. Systems and Personalized Medicine—Application of systems biology and data-driven personalization for patient-specific intervention planning. Systems and Personalized Medicine—Application of systems biology and data-driven personalization for patient-specific intervention planning. Psychosocial and Behavioural Foundations of Healthy Ageing—Understanding the social, behavioural, and psychological determinants of health and longevity, including health behaviours, patient motivation, adherence, social support structures, and cultural attitudes toward ageing. Basic sociology and psychology principles help clinicians contextualize biological interventions within real-world human behaviour, improving the effectiveness and equity of longevity care. Psychosocial and Behavioural Foundations of Healthy Ageing—Understanding the social, behavioural, and psychological determinants of health and longevity, including health behaviours, patient motivation, adherence, social support structures, and cultural attitudes toward ageing. Basic sociology and psychology principles help clinicians contextualize biological interventions within real-world human behaviour, improving the effectiveness and equity of longevity care. Professional and Ethical Foundations—Communication, interdisciplinary teamwork, transparency, medical marketing ethics, and the societal implications of longevity interventions. Patient priorities in later life also extend beyond biomarker optimization—Healthspan care requires shared decision making that respects individual goals, particularly in advanced age where quality of life may supersede preventive ambitions. Professional and Ethical Foundations—Communication, interdisciplinary teamwork, transparency, medical marketing ethics, and the societal implications of longevity interventions. Patient priorities in later life also extend beyond biomarker optimization—Healthspan care requires shared decision making that respects individual goals, particularly in advanced age where quality of life may supersede preventive ambitions. Policy and Global Health Perspectives—Understanding demographic transitions, socioeconomic determinants of ageing, and the role of longevity policy in public health planning. Policy and Global Health Perspectives—Understanding demographic transitions, socioeconomic determinants of ageing, and the role of longevity policy in public health planning. These domains could be adapted to local contexts while aiming for broadly harmonised learning outcomes and assessment criteria. Beyond content mastery, curricula should emphasize competency-based assessment, focusing on critical appraisal, data interpretation, and ethical application. Integration between domains—such as linking biomarker interpretation with clinical decision-making or aligning ethical frameworks with digital data governance—may be beneficial to avoid siloed learning. Pedagogical model: a blended, modular approach Longevity education must reflect the interdisciplinary nature of the field. A blended learning model—combining asynchronous online modules, interactive case discussions, and in-person workshops—enables professionals to balance their ongoing clinical or healthcare practice and study. Modular progression allows learners to advance from theoretical foundations to applied clinical integration, supported by structured supervision and mentorship. Experienced longevity physicians and geroscientists act as mentors, guiding clinicians through translational casework and reflective practice. This supervision framework may help define a potential clinical training pathway for longevity physicians—linking laboratory geroscience with bedside decision-making and ensuring safe, evidence-based translation into practice. This blended and modular structure aligns with established principles of adult learning and competency-based medical education (CBME). Incorporating reflective practice, peer learning, and structured mentorship bridges the translational gap between bench science and bedside care. Hybrid formats, such as those offered by the Geneva College of Longevity Science,—combining digital learning, clinical simulation, and supervised mentorship—may support scalability across geographies, though quality assurance will remain context dependent. Accreditation and quality assurance To support legitimacy, longevity-related educational programs may need to adhere to established academic standards and, where applicable, obtain recognition from medical regulatory or professional bodies. Accreditation by higher-education authorities ensures academic quality and transparency, while endorsement by medical associations supports professional and ethical compliance. Programs should employ clear outcome metrics, such as completion rates, demonstrated competencies, and evidence of clinical application. Moreover, alignment with international frameworks—such as those of the World Health Organization (WHO, 2015) or European Standards and Guidelines for Quality Assurance (ENQA, 2015)—can help distinguish evidence-based longevity education from commercial wellness training. In parallel, ethical and regulatory literacy must be embedded as core competencies. Longevity physicians are expected to navigate evolving frontiers—genetic testing, biomarker interpretation, and off-label interventions—with professional integrity and adherence to regulatory standards. Embedding ethics, data governance, and translational responsibility in the accreditation process may help reduce the risk that educational initiatives outpace scientific validation or patient safety. Given current regulatory structures, the most feasible pathway is CME-based certification and academic postgraduate diplomas integrated into existing specialties. Longevity medicine is positioned not as a standalone specialty at this stage, but as a cross-specialty competency domain analogous to sleep medicine or clinical nutrition during their developmental phases. The proposed training does not imply the creation of a new professional category. Instead, it defines a cross-cutting competency layer that can be incorporated by physicians already embedded in existing pathways. In gatekeeper systems, these competencies naturally align with the responsibilities of general practitioners, who remain the primary coordinators of preventive and diagnostic care. In specialist-led systems, the competencies may be integrated into existing disciplines such as internal medicine, cardiology, endocrinology, or preventive medicine, similar to how sleep medicine and clinical nutrition evolved as subspecialty skill sets rather than standalone professions. Global and societal dimensions Longevity science is inherently global, yet its implementation must adapt to regional realities. Regional adaptations may include cost-sensitive approaches, integration of local epidemiological data, and culturally informed pedagogy. Societies with rapidly ageing populations—such as Europe, East Asia, and the Middle East—face differing healthcare infrastructures and policy priorities. A coordinated global approach to education may contribute to greater consistency without imposing uniformity. Shared frameworks could mirror the evolution of cardiology or endocrinology from emerging disciplines to standardised medical specialties. While longevity education must reflect global scientific standards, it should also address inequities in access to care and technology. Furthermore, psychosocial influences—including health literacy, social connectedness, behavioural patterns, and cultural attitudes toward ageing—play a critical role in shaping healthspan trajectories. Integrating these dimensions into longevity education may better equip clinicians with the knowledge to address not only biological mechanisms but also the lived experience of patients across diverse populations. Challenges ahead Although longevity medicine is often perceived as expensive and thereby of limited value to the broader population, its core interventions are not dependent on high-cost diagnostics or advanced omics platforms. The majority of clinically meaningful longevity practices derive from behavioural, lifestyle, and pharmacological risk-reduction strategies—low-cost, high-impact measures that align closely with existing public-health and insured care models. These foundational approaches can be augmented by mid-cost diagnostics, such as continuous glucose monitoring or validated digital biomarkers, which are increasingly accessible across diverse healthcare settings. In contrast, high-cost emerging tools—including extensive multi-omics panels or full-body MRI screening—have gained visibility in consumer markets but do not automatically constitute a general backbone for longevity medicine. Current evidence does not support their routine use, and they should be considered optional, context-specific adjuncts rather than recommended standards of care, ensuring wider affordability of longevity medicine. Several barriers remain. Longevity medicine lacks universally accepted diagnostic classifications, insurance frameworks, and validated clinical endpoints. Its multidisciplinary nature—spanning molecular biology, clinical medicine, lifestyle intervention and technology -makes curriculum development complex. It also impacts the success of implementing learning into practice. A recent review of continuous professional development activities in healthcare education showed that the complexity of the educational concepts was a frequently reported barrier. (Al-Omary et al., 2024) Parallel initiatives in developing curricula for ageing and longevity medicine demonstrate the field’s momentum but also illustrate the variability in scope, standards, and intended competencies that must be reconciled to achieve global coherence. Moreover, commercial incentives risk outpacing scientific validation. Counteracting these pressures will require strong ethical governance, academic independence, and an unwavering commitment to evidence-based practice. Conclusion: building the human infrastructure for longevity Potential shifts toward more healthspan-oriented care may depend not only on scientific innovation but on cultivating clinicians who can interpret and apply longevity science with precision and integrity. Structured education may contribute to the human infrastructure needed for any potential shifts in practice, recognising that such transitions are complex and system dependent. By institutionalizing curricula, accreditation, and international collaboration, longevity medicine may evolve into a disciplined, evidence-based field that expands both healthspan and professional accountability. Future progress in longevity-related care may depend as much on educational advances as on scientific discovery. Educating longevity physicians, therefore, is a public health imperative. The path from sick care to healthspan begins in the classroom. Acknowledgements The authors apologize for not citing all relevant papers due to space constraints. Y.X.L. is supported by Southern University of Science and Technology and SIRIO Pharma Co., Ltd. Author contributions Writing-original draft preparation, D.T..; Writing-review and editing, conceptualization, supervision, D.B., D.T., Y.X.L., L.S. All authors have read and agreed to the published version of the manuscript. Data availability No datasets were generated or analysed during the current study. Declarations Conflict of interest The authors declare that the manuscript was written without any commercial or financial relationships that could be construed as a potential conflict of interest. Footnotes The original online version of this article was revised due to removal of duplicate paragraph. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Dominik Thor, David Barzilai, Yu-Xuan Lyu, and Luiza Spiru have contributed equally to this work. Change history 4/18/2026 The original online version of this article was revised due to removal of duplicate paragraph. Change history 4/21/2026 A Correction to this paper has been published: 10.1007/s10522-026-10433-0 References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.